Fig. 3From: Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trialChange in total entheseal inflammation score and total structural damage at weeks 24 and 52. A Area of Achilles tendon. B Area of plantar fascia. Patients on PBO received active SEC treatment from week 24 to week 52. n, number of patients; PBO, placebo; SEC, secukinumabBack to article page